Evidence map›Paper›PMID 15306649›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2004

Serotonergic regulation of the orexin/hypocretin neurons through the 5-HT1A receptor.

Yo Muraki, Akihiro Yamanaka, Natsuko Tsujino, Thomas S Kilduff, Katsutoshi Goto, Takeshi Sakurai

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 205 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Physiological Role of Orexinergic System for Health.International journal of environmental research and public health · 2022
    Review
  9. Article
  10. Roles of Neuropeptides in Sleep-Wake Regulation.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Review
  13. Orexin, serotonin, and energy balance.WIREs mechanisms of disease · 2022
    Review
  14. Sleep dysregulation in binge eating disorder and "food addiction": the orexin (hypocretin) system as a potential neurobiological link.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Review
  15. Serotonin, food intake, and obesity.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2021
    Review
  16. Hypocretin (Orexin) Replacement Therapies.Medicine in drug discovery · 2020
    Article
  17. Article
  18. Dopamine DThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  19. Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yo MurakiDepartment of Pharmacology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Akihiro Yamanaka
Natsuko Tsujino
Thomas S Kilduff
Katsutoshi Goto
Takeshi Sakurai
University of Tsukuba · JPSRI International · US

Funding

NEUROBIOLOGICAL STUDIES OF A NOVEL HYPOTHALAMIC PEPTIDER01MH061755 · NIMH · SRI INTERNATIONAL · PI KILDUFF, THOMAS S · 1999 to 2007
$3.0M
NIMH NIH HHS R01 MH061755NIMH NIH HHS R01MH61755
6 · The paper itself

Abstract

Both orexin and serotonin (5-HT) have important roles in the regulation of sleep-wakefulness, as well as in feeding behavior. We examined the effects of 5-HT on orexin/hypocretin neurons, using hypothalamic slices prepared from orexin/enhanced green fluorescent protein (EGFP) transgenic mice in which EGFP is expressed exclusively in orexin neurons. Patch-clamp recording from EGFP-expressing cells showed that 5-HT hyperpolarized all orexin neurons in a concentration-dependent manner. The response was inhibited by the 5-HT1A receptor antagonist WAY100635. A 5-HT1A receptor agonist, 8-hydroxy-2-(dl-N-propyl-amino)tetralin, also evoked hyperpolarization on orexin neurons with potency comparable with 5-HT. A low concentration of Ba2+ (30 microM) inhibited 5-HT-induced hyperpolarization. Single-channel recording revealed that the conductance of 5-HT-induced channel activity was 33.8 pS, which is in good agreement with that of the G-protein-coupled inward rectifier potassium channel (GIRK). Moreover, 5-HT1A receptor-like immunoreactivity was observed on orexin neurons, and 5-HT transporter immunoreactive nerve endings are in close apposition to orexin neurons. Intracerebroventricular injection of the 5-HT1A receptor-selective antagonist WAY100635 (100 ng) increased locomotor activity during the latter half of dark phase in wild-type mice but not in orexin/ataxin-3 mice in which orexin neurons are specifically ablated, suggesting that activation of orexin neurons is necessary for the WAY100635-induced increase in locomotor activity. These results indicate that 5-HT hyperpolarizes orexin neurons through the 5-HT1A receptor and subsequent activation of the GIRK and that this inhibitory serotonergic input to the orexin neurons is likely to be important for the physiological regulation of this neuropeptide system.

Indexed as

AnimalsAtaxin-3FemaleG Protein-Coupled Inwardly-Rectifying Potassium ChannelsGreen Fluorescent ProteinsHypothalamusImmunohistochemistryInjections, IntraventricularIntracellular Signaling Peptides and ProteinsIn Vitro TechniquesMaleMembrane GlycoproteinsMembrane Transport ProteinsMiceMice, Inbred C57BLMice, TransgenicAtaxin-3ATXN3 protein, humanAtxn3 protein, mouseenhanced green fluorescent proteinG Protein-Coupled Inwardly-Rectifying Potassium ChannelsGreen Fluorescent ProteinsIntracellular Signaling Peptides and ProteinsMembrane GlycoproteinsMembrane Transport ProteinsNerve Tissue ProteinsNeuropeptidesNuclear ProteinsOrexin ReceptorsOrexinsPotassium Channels, Inwardly RectifyingReceptor, Serotonin, 5-HT1AReceptors, G-Protein-CoupledReceptors, NeuropeptideRepressor ProteinsSerotoninSerotonin AntagonistsSerotonin Plasma Membrane Transport ProteinsSerotonin Receptor AgonistsSlc6a4 protein, mouseTetrodotoxinTranscription Factors

Identifiers

PMID15306649
PMCPMC6729168
OpenAlexW2168219052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.